Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors. [electronic resource]
Producer: 20120709Description: 407-11 p. digitalISSN:- 1573-7373
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Brain -- drug effects
- Brain Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Glioblastoma -- drug therapy
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.